XML 46 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Associate Benefit Plans (Tables)
12 Months Ended
Sep. 02, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Stock-Based Compensation Expense



 

 

 

 

 

 

 

 

 



 

For the Fiscal Years Ended

  

 

September 2,

 

September 3,

 

August 29,



 

2017

 

2016

 

2015

Stock options

 

$

4,369 

 

$

4,382 

 

$

4,614 

Restricted share awards

 

 

4,399 

 

 

6,112 

 

 

8,139 

Restricted stock units

 

 

4,872 

 

 

3,205 

 

 

1,105 

Associate Stock Purchase Plan

 

 

285 

 

 

286 

 

 

337 

Total

 

 

13,925 

 

 

13,985 

 

 

14,195 

Deferred income tax benefit

 

 

(5,292)

 

 

(5,206)

 

 

(5,266)

Stock-based compensation expense, net

 

$

8,633 

 

$

8,779 

 

$

8,929 



Schedule Of Option Grant Fair Value Assumptions



 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

 

 

 

 



 

 

 

 

 

 



 

2017

 

2016

 

2015

Expected life (in years)

 

4.1 

 

 

3.9 

 

 

3.9 

 

Risk-free interest rate

 

1.16 

%

 

1.09 

%

 

1.09 

%

Expected volatility

 

20.5 

%

 

21.8 

%

 

24.5 

%

Expected dividend yield

 

2.40 

%

 

2.40 

%

 

1.70 

%

Weighted-Average Grant-Date Fair Value

$

9.29 

 

$

8.03 

 

$

14.06 

 



 

 

 

 

 

 

 

 

 



Summary Of Stock Option Activity



 

 

 

 

 



 

2017



 

Shares

 

Weighted-Average Exercise Price

Outstanding - beginning of year

 

1,645 

 

$

69.86 

Granted

 

537 

 

 

71.33 

Exercised

 

(399)

 

 

67.36 

Canceled/Forfeited

 

(40)

 

 

70.20 

Outstanding - end of year

 

1,743 

 

$

70.88 

Exercisable - end of year

 

585 

 

$

74.23 



Summary Of Stock Options By Range Of Exercise Price



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Range of Exercise Prices

 

Number of Options Outstanding at September 2, 2017

 

Weighted-Average Remaining Contractual Life

 

Weighted-Average Exercise Price

 

Intrinsic Value

 

Number of Options Exercisable at September 2, 2017

 

Weighted-Average Remaining Contractual Life

 

Weighted-Average Exercise Price

 

Intrinsic Value

$  58.90 – $ 66.69

 

554 

 

4.8 

 

$

59.61 

 

$

5,296 

 

147 

 

3.8 

 

$

61.58 

 

$

1,111 

   66.70 –    71.33

 

650 

 

5.4 

 

 

70.96 

 

 

 —

 

128 

 

2.1 

 

 

69.46 

 

 

 —

   71.34 –    81.76

 

236 

 

3.1 

 

 

81.57 

 

 

 —

 

171 

 

3.1 

 

 

81.51 

 

 

 —

   81.77 –    83.03

 

303 

 

4.1 

 

 

83.02 

 

 

 —

 

139 

 

4.1 

 

 

83.03 

 

 

 —

  

 

1,743 

 

4.7 

 

$

70.88 

 

$

5,296 

 

585 

 

3.3 

 

$

74.23 

 

$

1,111 



Restricted Share Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary Of Non-Vested Restricted Share Award Activity



 

 

 

 



2017



Shares

 

 

Weighted-Average Grant-Date Fair Value

Non-vested restricted share awards at the beginning of the year

265 

 

$

78.58 

Granted

 —

 

 

 -

Vested

(98)

 

 

75.24 

Canceled/Forfeited

(7)

 

 

81.07 

Non-vested restricted share awards at the end of the year

160 

 

$

80.49 



 

 

 

 



Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary Of Non-Vested Restricted Stock Unit Award Activity



 

 

 

 



2017



Shares

 

 

Weighted-Average Grant-Date Fair Value

Non-vested restricted stock unit awards at the beginning of the year

198 

 

$

58.98 

Granted

174 

 

 

73.33 

Vested

(45)

 

 

59.15 

Canceled/Forfeited

(14)

 

 

65.21 

Non-vested restricted stock unit awards at the end of the year

313 

 

$

66.66